Thus, potential mechanisms by which inhibition of PDH may drive the development of diabetic cardiomyopathy include a reduction in the energetic capacity of the heart, particularly in response to increased physiologic demand, and the induction of a state of chronic oxidative stress. The gene discussed is PDP1; the disease is diabetic cardiomyopathy.